MedTrace Logo

Identifying Periods of High Training Load Considering the Menstrual Cycle Phases in Elite and Non-elite Female Athletes

NCT06377306 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-04-22

No results posted yet for this study

Summary

Despite a rise in the number of women participating in competitive sports, there remains a gender gap within sport and exercise science literature. Studying females involves potential "noise" through the change in hormone concentrations during the different phases of the female menstrual cycle (MC) which can potentially affect physiological parameters, thereby making study design and interpretation of findings difficult. Longitudinal data on the acute and chronic combined effects of training load and MC phases on circulating female hormones in elite and non-elite female athletes is lacking.

The investigators aim to characterize and track the potential effects of training load and MC phases on performance, anthropometric measures, sport emotions, intestinal microbiome, serum metabolites and injury prevalence in elite and non-elite female athletes.

200 competitive premenopausal female athletes will be recruited. In a longitudinal observational design, each participant will be followed for 1 year, and tested at three time points. At each point, data will be collected on two occasions reflecting distinct phases of the MC.

Finding the possible relationship between the MC phases, training load and performance or specific bio-markers for training load are of utmost importance and can assist professionals to identify periods of high load and over-training, thus preventing injuries and training adjustment.

Conditions

  • Menstrual Cycle
  • Athletes
  • Physical Activity

Interventions

BEHAVIORAL

Effect of training loads and sport performance level on health and sport performance

Effect of training loads and sport performance level on health and sport performance

Sponsors & Collaborators

  • Weizmann Institute of Science

    collaborator OTHER

  • Kaplan Medical Center

    collaborator OTHER

  • Ministry of Innovation, Science and Technology of Israel

    collaborator UNKNOWN

  • Wingate Institute

    lead OTHER

Principal Investigators

  • Rotem Kislev-Cohen, Ph.D · Wingate Institute

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-05
Primary Completion
2026-01-30
Completion
2027-01-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06377306 on ClinicalTrials.gov